PresseBox
Press release BoxID: 155558 (Eckert & Ziegler Strahlen- und Medizintechnik AG)
  • Eckert & Ziegler Strahlen- und Medizintechnik AG
  • Robert-Rössle-Str. 10
  • 13125 Berlin
  • http://www.ezag.de
  • Contact person
  • Thomas Scheuch
  • +49 (30) 941084-139

Eckert & Ziegler: New Board member Dr. André Heß to direct radiopharmaceuticals segment

(PresseBox) (Berlin, ) The Supervisory Board of Eckert & Ziegler AG (ISIN DE 0005659700) has appointed Dr. André Heß to be the third member of the Executive Board as of 1 March 2008. He will assume directorship of the radiopharmaceuticals segment with the objective of evolving this segment into a strong pillar of the group.

Following his studies in chemistry and economic engineering as well as a research position (wissenschaftlicher Mitarbeiter) at the Humboldt University in Berlin, André Heß joined what would become Eckert & Ziegler AG as a radiochemist in 1996, where he directed the development department. In 1999 he was appointed managing director of Eckert & Ziegler Eurotope GmbH, which develops and markets radioactive medical implants as well as the associated production technology on an international scale. Since 2005 he has been in charge of development, production, and sales of innovative radiopharmaceutical synthesis systems as well as customized development for radiopharmaceutical production technologies within the radiopharmaceuticals segment of Eckert & Ziegler AG.

In the words of Supervisory Board Chairman Professor Wolfgang Maennig, "With the Modular Lab family of synthesis systems, André Heß and his team have demonstrated over the past years that they can successfully develop and introduce new products onto the market. It is therefore only logical to give Mr. Heß greater responsibilities and to make use of his abilities for the entire segment. We see considerable opportunities for growth in the radiopharmaceuticals sector for Eckert & Ziegler. With the appointment of Mr. Heß, we want to ensure that sufficient management capacities are available for further expansion."

Eckert & Ziegler Strahlen- und Medizintechnik AG

For over forty (40) years, Eckert & Ziegler Isotope Products, (a subsidiary of Eckert & Ziegler AG) has been producing instrumentation and calibration standards. Today it is the world's leading manufacturer for nuclear imaging reference and calibration standards and a leading producer of radioactive components for industrial, scientific and medical applications.

Eckert & Ziegler AG is a global isotope technology company that processes radioisotopes as well as develops, manufactures and sells isotope technology components, medical technology equipment and related products.

Eckert & Ziegler employs over 430 people worldwide. Throughout all of its subsidiaries it generates yearly consolidated revenues in excess of $ 83 MM(54 Mio. EUR). Eckert & Ziegler AG is listed in the Prime Standard of the German Stock Exchange in Frankfurt am Main (ISIN DE0005659700).